Home > Insider Trading > Fate Therapeutics Inc

Fate Therapeutics Inc (FATE)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

Hedge Fund and Insider Trading News: Seth Fischer, Ray Dalio, Jupiter Fund Management, Calculo Capital, Enphase Energy Inc (ENPH), Fate Therapeutics, Inc. (FATE), and More

Nichola Pease has quit as boss of Jupiter Fund Management for ‘personal reasons’ after just three years.

Keep Reading →

April 27th, 2023 - Hedge Funds Insider Trading

5 Best Low-Priced Growth Stocks To Buy

ADMA Biologics, Inc. (NASDAQ:ADMA) is a biotech company whose shares have shown a remarkable performance over the past 12 months, gaining about 80% in value. In March, ADMA Biologics, Inc.

Keep Reading →

April 16th, 2023 - Hedge Funds News

Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2022 Earnings Call Transcript

Operator: Welcome to the Fate Therapeutics Fourth Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

March 2nd, 2023 - News Transcripts

12 Cash-Rich Small Cap Stocks To Invest In

In 2022, standard diversified portfolios suffered through their worst-performing year in a century.

Keep Reading →

January 28th, 2023 - Hedge Funds News

Hedge Fund and Insider Trading News: Chris Hohn, Cathie Wood, ValueAct Capital, Rokos Capital Management, Brevan Howard Asset Management, DiamondHead Holdings Corp (DHHC), Appian Corporation (APPN), and More

Famed activist investor and philanthropist Chris Hohn’s fund lost money last year, breaking its streak of 13 straight profitable years as stocks tumbled.

Keep Reading →

January 20th, 2023 - Hedge Funds Insider Trading

Hedge Fund and Insider Trading News: Boaz Weinstein, Greenlight Capital, Bridgewater Associates, Trian Fund Management, Three Arrows Capital, LHG Capital Management, Fate Therapeutics Inc (FATE), Werewolf Therapeutics, Inc. (HOWL), and More

Hedge fund manager Boaz Weinstein doesn't believe Credit Suisse will default on its debt but if it does, the derivatives trade he has on the bank may win big, highlighting just how hedge funds use volatile...

Keep Reading →

January 17th, 2023 - Hedge Funds Insider Trading

Analysts Are Downgrading These 5 Stocks

Truist analyst Robyn Karnauskas lowered her ratings for Fate Therapeutics, Inc. (NASDAQ:FATE) from "Buy" to "Hold" on Friday, January 6.

Keep Reading →

January 10th, 2023 - News

5 Most Shorted Stocks Hedge Funds Are Buying

Fate Therapeutics, Inc. (NASDAQ:FATE) is a clinical-stage biopharmaceutical company that develops cell therapies for the treatment of cancer and other diseases.

Keep Reading →

December 28th, 2022 - News